Front & Back Matter.
- Published in:
- Chemotherapy (0009-3157), 2019, v. 64, n. 2, p. 1, doi. 10.1159/000504329
- Publication type:
- Article
Works matching IS 00093157 AND DT 2019 AND VI 64 AND IP 2
Results: 7
1
2
Effectiveness and Safety of Combination Therapy of Transarterial Chemoembolization and Apatinib for Unresectable Hepatocellular Carcinoma in the Chinese Population: A Meta-Analysis.
- Published in:
- Chemotherapy (0009-3157), 2019, v. 64, n. 2, p. 94, doi. 10.1159/000502510
- By:
- Publication type:
- Article
3
Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy.
- Published in:
- Chemotherapy (0009-3157), 2019, v. 64, n. 2, p. 110, doi. 10.1159/000502473
- By:
- Publication type:
- Article
4
Successful Treatment of Severe Aspergillosis with Isavuconazole Therapy after Allogeneic Stem Cell Transplantation.
- Published in:
- Chemotherapy (0009-3157), 2019, v. 64, n. 2, p. 57, doi. 10.1159/000502279
- By:
- Publication type:
- Article
5
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients.
- Published in:
- Chemotherapy (0009-3157), 2019, v. 64, n. 2, p. 105, doi. 10.1159/000501195
- By:
- Publication type:
- Article
6
Treatment Selection for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors.
- Published in:
- Chemotherapy (0009-3157), 2019, v. 64, n. 2, p. 81, doi. 10.1159/000501061
- By:
- Publication type:
- Article
7
On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment.
- Published in:
- Chemotherapy (0009-3157), 2019, v. 64, n. 2, p. 62, doi. 10.1159/000500902
- By:
- Publication type:
- Article